Skip to main content
. 2013 Nov;34(11):2113–2118. doi: 10.3174/ajnr.A3567

Table 1:

Clinical characteristics of patient and control groups

Early Parkinson Disease Late Parkinson Disease Alzheimer Disease Control
Patients, n 13 31 6 20
Hoehn and Yahr stage I:3, II:10 III:16, IV:12, V:3 / /
Male/female 5/8 14/17 3/3 5/15
Age, y, mean ± SD 68.3 ± 5.88 71.8 ± 8.95 75.7 ± 9.52 74.8 ± 5.41
Duration, y, mean ± SD 4.30 ± 5.37 9.48 ± 6.86 2.5 ± 3 /
Hasegawa Dementia Scale-Revised, mean ± SD / / 12.8 ± 4.76 /

Note:—Age does not differ between patient and control groups (P = .082; 1-way analysis of variance).

HHS Vulnerability Disclosure